Average Co-Inventor Count = 4.91
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (9 from 1,384 patents)
2. Novo Nordisk A/s (2 from 1,777 patents)
3. Other (1 from 832,843 patents)
4. Bayer Pharma Aktiengesellschaft (1 from 378 patents)
5. Bayer Schering Pharma Ag (1 from 192 patents)
6. Novo Nordisk D/s (1 from 1 patent)
12 patents:
1. 9708311 - Benzimidazole derivatives as EP4 antagonists
2. 7683081 - 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
3. RE39678 - Meiosis regulating compounds
4. 7196202 - 1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
5. 6962932 - 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
6. 6946466 - Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
7. 6916921 - Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
8. 6903126 - 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
9. 6884796 - Meiosis regulating compounds
10. 6855714 - 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
11. 6683197 - Process for the production of 4,4-dimethyl-5&agr;-cholesta-8,14,24-trien-3&bgr;-01 and intermediate products in process (I)
12. 6407086 - Meiosis regulating compounds